Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 432.00
Bid: 426.00
Ask: 440.00
Change: 0.00 (0.00%)
Spread: 14.00 (3.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 432.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of the 2020 Annual General Meeting

8 Jun 2020 14:06

RNS Number : 2926P
Zotefoams PLC
08 June 2020
 

Zotefoams plc

 

Result of the 2020 Annual General Meeting

 

The 2020 Annual General Meeting of Zotefoams plc was held at the offices of Zotefoams plc, 675 Mitcham Road, Croydon CR9 3AL on 8 June 2020.

 

Proxy votes were received from shareholders in respect of 22,890,906 ordinary shares amounting to 47.1% of the issued share capital. The total number of ordinary shares in issue in relation to the AGM is 48,621,234.

 

All resolutions put to the meeting were passed on a show of hands. The proxy votes cast in respect of the resolutions received prior to the meeting were as follows:

 

Resolution

For

Against

Discretion

Votes Withheld

1.

To receive the Annual Report of the Company for the year ended 31 December 2019.

22,875,128

4,078

11,699

 

0

2.

To approve the New Directors' Remuneration Policy.

20,542,091

2,331,595

12,699

4,520

3.

To approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2019.

22,866,741

 

9,931

12,699

 

1,384

4.

To elect A M Fielding as a Director.

22,879,207

 

0

11,699

 

0

5.

To elect C.A Wall as a Director

.

22,879,207

0

11,699

0

6.

To re-elect S P Good as a Director.

21,999,130

876,940

 

11,699

 

3,136

7.

To re-elect D B Stirling as a Director.

22,876,093

3,114

 

11,699

 

0

8.

To re-elect G C McGrath as a Director.

22,876,093

 

3,114

 

11,699

 

0

9.

To re-elect D G Robertson as a Director.

22,876,071

 

0

 

11,699

3,136

10.

To re-elect J D Carling as a Director.

22,879,207

 

0

 

11,699

 

0

11.

To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company.

22,758,354

 

853

11,699

 

120,000

 

12.

To authorise the Audit Committee to determine the Auditors' remuneration.

22,878,354

 

853

11,699

 

0

 

13.

To authorise the Directors to allot shares.

22,678,500

 

195,685

 

13,585

 

3,136

 

14.

To authorise the Directors to allot equity securities for cash.

22,747,057

 

132,150

 

11,699

 

0

 

15.

To authorise the Directors, in addition to resolution 14, to allot further equity securities for financing (and refinancing) purposes only.

22,742,978

 

136,228

 

11,699

 

0

 

16.

To authorise market purchases of shares.

22,874,816

 

4,390

 

11,699

 

0

 

17.

That a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice.

22,588,685

 

290,522

 

11,699

 

0

 

Resolutions 1 to 13 inclusive were passed as ordinary resolutions and resolutions 14 to 17 inclusive were passed as special resolutions.

 

Further details of the resolutions (including the text of the resolutions) are given in the Notice of the 2020 Annual General Meeting which is at the rear of the 2019 Annual Report and which is also available on the Company's website.

 

Lydia Harratt

Group Company Secretary

8 June 2020

 

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGXVLFBBQLBBBZ
Date   Source Headline
3rd Jul 20174:35 pmRNSPrice Monitoring Extension
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20172:14 pmRNSDirector/PDMR Shareholding
1st Jun 20174:30 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSDirector/PDMR Shareholding
17th May 20177:00 amRNSTrading Update
12th May 201711:16 amRNSDirector/PDMR Shareholding
12th Apr 20173:34 pmRNSAnnual Report and Accounts and Notice of 2017 AGM
12th Apr 20173:24 pmRNSDirector/PDMR Shareholding
12th Apr 20171:55 pmRNSHolding(s) in Company
10th Apr 20174:02 pmRNSDirector/PDMR Shareholding
6th Apr 20172:27 pmRNSHolding(s) in Company
6th Apr 20172:25 pmRNSHolding(s) in Company
28th Mar 201711:36 amRNSDirector/PDMR Shareholding
27th Mar 201710:16 amRNSHolding(s) in Company
24th Mar 20173:33 pmRNSHolding(s) in Company
23rd Mar 201710:11 amRNSHolding(s) in Company
22nd Mar 20173:28 pmRNSHolding(s) in Company
14th Mar 20175:28 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSFinal Results
9th Mar 20177:00 amRNSCoveris using MuCell® technology
15th Feb 201710:46 amRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSHolding(s) in Company
1st Feb 20176:27 pmRNSHolding(s) in Company
12th Jan 20179:36 amRNSDirector/PDMR Shareholding
11th Jan 201710:33 amRNSHolding(s) in Company
10th Jan 20175:34 pmRNSHolding(s) in Company
9th Jan 20177:00 amRNSTrading Update
6th Jan 20177:00 amRNSAppointment of Joint Broker
6th Jan 20177:00 amRNSAcquires full ownership of its joint venture
22nd Dec 20164:35 pmRNSPrice Monitoring Extension
13th Dec 20161:58 pmRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSHolding(s) in Company
15th Nov 201612:40 pmRNSDirector/PDMR Shareholding
14th Nov 201610:30 amRNSDirector Declaration
28th Oct 20167:00 amRNSThird Quarter Trading Update
25th Oct 20164:40 pmRNSSecond Price Monitoring Extn
25th Oct 20164:35 pmRNSPrice Monitoring Extension
24th Oct 201612:07 pmRNSSecond Price Monitoring Extn
24th Oct 201612:02 pmRNSPrice Monitoring Extension
20th Oct 20164:40 pmRNSSecond Price Monitoring Extn
20th Oct 20164:35 pmRNSPrice Monitoring Extension
19th Oct 20163:43 pmRNSHolding(s) in Company
18th Oct 201611:56 amRNSDirector/PDMR Shareholding
14th Oct 20164:35 pmRNSPrice Monitoring Extension
13th Oct 20164:35 pmRNSPrice Monitoring Extension
12th Oct 20165:56 pmRNSDirector/PDMR Shareholding
5th Oct 20164:29 pmRNSHolding(s) in Company
14th Sep 201611:16 amRNSDirector/PDMR Shareholding
23rd Aug 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.